Synthetic palm oil start-up raises $20m from Bill Gates-led fund

The financial backers for C16 Bioscience include also beauty investment specialists Waldencast

A synthetic palm oil manufacturer has raised US$20m in funding to scale its technology and prepare the business for commercial launch.

C16 Biosciences uses . . .

This is a small extract of the full article which is available ONLY to premium content subscribers. Subscribers sign-in (top right) to read the article.


Subscribe now to premium content on Cosmetics Business